.svg){kind=small}
Where to Buy
Inflorescence is stocked at 13 licensed dispensaries across Washington and New Mexico, 12 of them in Washington, with the deepest coverage in Seattle, Des Moines, Ellensburg, Lynnwood, and Millwood. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Inflorescence concentrated 96.75% of sales in Flower with year-over-year growth of 60.07% and month-over-month growth of 14.68%, while Pre-Roll held 3.25% share with a year-over-year decline of 26.63% and a month-over-month decline of 28.45%. Average price in July 2026 edged up 0.37% year over year to $15.30, while Flower’s average price sat at $16.08 as Pre-Roll averaged $6.26, indicating a mix shift toward higher-priced units as Flower expanded share by 14.68% MoM and Pre-Roll contracted by 28.45% MoM. The pattern implies Inflorescence is leaning into a single-category strategy where Flower’s accelerating growth offsets Pre-Roll contraction, concentrating revenue risk but amplifying momentum in its core.
With Flower ranked 31 in Washington for July 2026 and Flower share at 96.75%, the brand’s positioning prioritizes depth over breadth as category dominance rises faster than portfolio diversification; the 60.07% YoY surge in Flower against a 26.63% YoY drop in Pre-Roll points to resource allocation that favors higher-velocity SKUs. Given brand-level sales up 40.94% YoY alongside a 14.68% MoM gain in Flower and a 28.45% MoM pullback in Pre-Roll, the mix implies a deliberate trade-off: rank advancement in Flower is more attainable than rebuilding secondary categories at current price points, so sustaining growth likely depends on defending the $16.08 average price tier while selectively pruning underperforming Pre-Roll offerings.
Competitive Landscape
Inflorescence sits at rank #31 in Washington Flower in July 2026, improving 21 positions from #52 year over year and climbing 19 spots from #50 in April 2026; this new peak rank of #31 in July 2026 arrives while Phat Panda held #1 with an 18.6% YoY sales increase and Legends stayed at #2 despite a 22.9% YoY sales decline, indicating Inflorescence’s ascent is occurring amid both entrenched leadership and volatility at the top. The pattern implies Inflorescence’s recent rank momentum is more about outpacing mid-tier peers than displacing top leaders, setting expectations for incremental share capture rather than immediate top-10 penetration.
Notable Products
Bubba's Cake (3.5g) set the tone in July 2026 with a -8.7% month-over-month decline while holding rank 1, whereas Bubba's Cake (7g) climbed to rank 2 on a +46.8% increase, creating a split signal within the same strain family. With eight of the top ten SKUs in Flower and multiple Mini Nugs formats inside the top 10, the rank concentration alongside a sub-10% drop at the leader and a near-50% surge at rank 2 implies a shift toward larger or value-oriented pack sizes within a tightly Flower-centric lineup.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
